Elzonris savings card: $0 a month with commercial insurance

Elzonris is given by a doctor or nurse and billed by the clinic, not a pharmacy. Your care team and your insurance decide which product you get, so ask them what you’d pay.

How to pay the least

Given by your care team

Billed by the clinic

Elzonris is given by a doctor or nurse, not picked up at a pharmacy.

Ask your care team or your plan what you’d pay before your visit.

Compare every option

Brand nameElzonris

Authorized generictagraxofusp

Regular generictagraxofusp

What you’d pay

Cash priceAsk the pharmacy

Not soldThere isn’t one

Not soldAsk the pharmacy

Same as Elzonris?

The original

–

Brand nameThe maker’s card

ELZONRIS Co-pay Card Program

Savings card from Stemline Therapeutics (a Menarini Group company)

No insuranceNeeds insuranceNo cash price listed.

Insurance $0 a month

The card takes up to $25,000 a year off your co-pay.

Or call 1-800-519-2140.

In the maker’s words

“With this card, eligible patients will pay a $0 co-pay per eligible monthly prescription, subject to a maximum amount of $25,000 per product per calendar year and a per fill maximum of $9,500.”

From the maker’s offer on elzonriscopay.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Authorized genericNot sold

There isn’t one. An authorized generic is Elzonris itself, from the same company, sold without the brand name, and usually for less. For now Elzonris is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Elzonris is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

BPDCN (a type of blood cancer)

What the FDA label says

ELZONRIS is a CD123-directed cytotoxin indicated for the treatment of blastic plasmacytoid dendritic cell neoplasm (BPDCN) in adults and in pediatric patients 2 years and older

Source: the FDA label for Elzonris (Stemline Therapeutics, Inc.), December 9, 2024. Full label on DailyMed

Good to know

“Commercial insurance” means a plan from a job, from the marketplace, or one you buy yourself. A retiree plan that’s part of Medicare counts as Medicare. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.
Most cards need a sign-up on the maker’s site, and many work only if your plan covers the drug. Then give the card’s details to the clinic’s billing office.
Don’t stop or change a medicine without talking to your pharmacist or prescriber.

Prices checked November 2, 2026. Prices change: confirm with the pharmacy before you fill. drugalt.com/drug/elzonris/